1F7M - Header Asymmetric Unit

HEADER BLOOD CLOTTING 19-FEB-99 1F7M

TITLE THE FIRST EGF-LIKE DOMAIN FROM HUMAN BLOOD COAGULATION FVII, TITLE 2 NMR, MINIMIZED AVERAGE STRUCTURE

COMPND MOL_ID: 1; COMPND 2 MOLECULE: PROTEIN (BLOOD COAGULATION FACTOR VII); COMPND 3 CHAIN: A; COMPND 4 FRAGMENT: FIRST EGF-LIKE DOMAIN; COMPND 5 ENGINEERED: YES; COMPND 6 OTHER_DETAILS: CALCIUM BOUND FORM

SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 6 EXPRESSION_SYSTEM_TAXID: 562

KEYWDS FACTOR VII, BLOOD COAGULATION, EGF-LIKE DOMAIN, BLOOD KEYWDS 2 CLOTTING

EXPDTA SOLUTION NMR

AUTHOR Y.-H.KAO,G.F.LEE,Y.WANG,M.A.STAROVASNIK,R.F.KELLEY, AUTHOR 2 M.W.SPELLMAN,L.LERNER

REVDAT 3 24-FEB-09 1F7M 1 VERSN REVDAT 2 01-APR-03 1F7M 1 JRNL REVDAT 1 16-JUN-99 1F7M 0

JRNL AUTH Y.H.KAO,G.F.LEE,Y.WANG,M.A.STAROVASNIK,R.F.KELLEY, JRNL AUTH 2 M.W.SPELLMAN,L.LERNER JRNL TITL THE EFFECT OF O-FUCOSYLATION ON THE FIRST EGF-LIKE JRNL TITL 2 DOMAIN FROM HUMAN BLOOD COAGULATION FACTOR VII. JRNL REF BIOCHEMISTRY V. 38 7097 1999 JRNL REFN ISSN 0006-2960 JRNL PMID 10353820 JRNL DOI 10.1021/BI990234Z

REMARK 1

REMARK 2 REMARK 2 RESOLUTION. NOT APPLICABLE.

REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : X-PLOR 3.851 REMARK 3 AUTHORS : BRUNGER REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: REFINEMENT DETAILS CAN BE FOUND IN REMARK 3 THE JRNL CITATION ABOVE.

REMARK 4 REMARK 4 1F7M COMPLIES WITH FORMAT V. 3.15, 01-DEC-08

REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 22-FEB-99. REMARK 100 THE RCSB ID CODE IS RCSB000509.

REMARK 210 REMARK 210 EXPERIMENTAL DETAILS REMARK 210 EXPERIMENT TYPE : NMR REMARK 210 TEMPERATURE (KELVIN) : 298 REMARK 210 PH : 5.5 REMARK 210 IONIC STRENGTH : 400MM REMARK 210 PRESSURE : 1 ATM REMARK 210 SAMPLE CONTENTS : NULL REMARK 210 REMARK 210 NMR EXPERIMENTS CONDUCTED : DQF-COSY, 2Q, TOCSY, NOESY, REMARK 210 1H-15N HSQC, 3D 1H-15N NOESY- REMARK 210 HSQC, 3D 1H-15N TOCSY-HSQC REMARK 210 SPECTROMETER FIELD STRENGTH : 500 MHZ REMARK 210 SPECTROMETER MODEL : INOVA 500 REMARK 210 SPECTROMETER MANUFACTURER : VARIAN REMARK 210 REMARK 210 STRUCTURE DETERMINATION. REMARK 210 SOFTWARE USED : FELIX, X-PLOR REMARK 210 METHOD USED : HYBRID DISTANCE GEOMETRY - REMARK 210 SIMULATED ANNEALING REMARK 210 REMARK 210 CONFORMERS, NUMBER CALCULATED : 100 REMARK 210 CONFORMERS, NUMBER SUBMITTED : 1 REMARK 210 CONFORMERS, SELECTION CRITERIA : NULL REMARK 210 REMARK 210 BEST REPRESENTATIVE CONFORMER IN THIS ENSEMBLE : NULL REMARK 210 REMARK 210 REMARK: DETAILS ARE INCLUDED IN THE PUBLICATION.

REMARK 215 REMARK 215 NMR STUDY REMARK 215 THE COORDINATES IN THIS ENTRY WERE GENERATED FROM SOLUTION REMARK 215 NMR DATA. PROTEIN DATA BANK CONVENTIONS REQUIRE THAT REMARK 215 CRYST1 AND SCALE RECORDS BE INCLUDED, BUT THE VALUES ON REMARK 215 THESE RECORDS ARE MEANINGLESS.

REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 GLN A 49 -60.14 -90.65 REMARK 500 CYS A 50 49.61 -93.97 REMARK 500 SER A 53 78.57 52.31 REMARK 500 GLN A 56 -164.58 -107.43 REMARK 500 GLN A 64 50.19 -118.29 REMARK 500 LEU A 65 123.76 61.80 REMARK 500 GLN A 66 -77.97 62.71 REMARK 500 SER A 89 -90.98 45.90 REMARK 500 REMARK 500 REMARK: NULL

DBREF 1F7M A 45 87 UNP P08709 FA7_HUMAN 83 125

SEQADV 1F7M GLY A 88 UNP P08709 SEE REMARK 999 SEQADV 1F7M SER A 89 UNP P08709 SEE REMARK 999 SEQADV 1F7M ALA A 90 UNP P08709 SEE REMARK 999

SEQRES 1 A 46 SER ASP GLY ASP GLN CYS ALA SER SER PRO CYS GLN ASN SEQRES 2 A 46 GLY GLY SER CYS LYS ASP GLN LEU GLN SER TYR ILE CYS SEQRES 3 A 46 PHE CYS LEU PRO ALA PHE GLU GLY ARG ASN CYS GLU THR SEQRES 4 A 46 HIS LYS ASP ASP GLY SER ALA

SHEET 1 S1 2 SER A 60 ASP A 63 0 SHEET 2 S1 2 TYR A 68 PHE A 71 -1 SHEET 1 S2 2 PHE A 76 GLU A 77 0 SHEET 2 S2 2 THR A 83 HIS A 84 -1

SSBOND 1 CYS A 50 CYS A 61 1555 1555 2.02 SSBOND 2 CYS A 55 CYS A 70 1555 1555 2.02 SSBOND 3 CYS A 72 CYS A 81 1555 1555 2.02

CRYST1 1.000 1.000 1.000 90.00 90.00 90.00 P 1 1

ORIGX1 1.000000 0.000000 0.000000 0.00000

ORIGX2 0.000000 1.000000 0.000000 0.00000

ORIGX3 0.000000 0.000000 1.000000 0.00000

SCALE1 1.000000 0.000000 0.000000 0.00000

SCALE2 0.000000 1.000000 0.000000 0.00000

SCALE3 0.000000 0.000000 1.000000 0.00000